PAG
ETTX

Private Advisor Group’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Private Advisor Group’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,000
Closed -$3K – 3754
2020
Q2 		$3K Buy
+1,000
New +$2.73K ﹤0.01% 3503

Other funds holding ETTX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Private Advisor Group's ETTX Position: Q3 2020 in Review

Private Advisor Group sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2020, closing a stake of 1,000 shares — an estimated $3K sold.

Private Advisor Group first reported a position in ETTX in Q2 2020 and held it in 1 quarter. The position peaked at $3K in Q2 2020. 30 funds tracked by Wall St. Rank hold ETTX as of Q3 2020.

  • Private Advisor Group reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 1,000 Entasis Therapeutics Holdings Inc. shares in Q3 2020, an estimated $3K.
  • Private Advisor Group first reported a position in Entasis Therapeutics Holdings Inc. in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's Entasis Therapeutics Holdings Inc. position peaked at $3K in Q2 2020.
  • 30 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.